Abstract
This text aims to provide a brief overview of tablet and capsule manufacturing approaches, to highlight some of the industrial engineering issues that exist in standard secondary manufacturing processes for oral solid dose products (which may often be overlooked by those who are unfamiliar with pharmaceutical production activities), and to provide a review of dose forms that are commonly employed for elderly patient groups. At present, a limited set of oral dose forms is used by the industry for this purpose, some of which formulation approaches offer potential benefits in terms of ease of swallowing by elderly patients, and these product types are considered briefly. The aim is to provide an overview and summary of existing formulation and manufacturing approaches that are used for the provision of dose forms for elderly patients, noting the associated practical issues and challenges.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Collins JC, Porras JI. Built to last. New York: Random House; 1994.
Pattina J. Should the marketing division set the strategy for pharmaceutical R&D? Forbes. http://www.forbes.com/sites/johnlamattina/2013/12/19/should-the-marketing-division-set-strategy-for-pharmaceutical-rd/#28f5f0481e68. Accessed 28 Apr 2016.
Mentzer D. Progress review of the European pediatric regulatory framework after six years of implementation. Int J Pharm. 2014;469:240–3.
Van Riet-Nales DA, Schobben AFAM, Egberts TCG, Rademaker CMA. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review. Clin Ther. 2010;32(5):924–38.
Association of British Pharmaceutical Industry (“ABPI”). http://www.abpi.org.uk/industry-info/knowledge-hub/global-industry/Pages/industry-market-.aspx. Accessed 21 Oct 2015.
Hapgood KP. Nucleation and binder dispersion in wet granulation. PhD Thesis, University of Queensland; 2000.
Summers MP, Aulton M. Granulation. In: Aulton ME, editor. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill-Livingstone (Elsevier Limited); 2007.
Aulton ME. Drying. In: Aulton ME, editor. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill-Livingstone (Elsevier Limited); 2007.
Nieuwmeyer F, van der voort Maarschalk K, Vromans H. Granule breakage during drying processes. Int J Pharm. 2007;329:81–7.
Alderborn G. Tablets and compaction. In: Aulton ME, editor. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill-Livingstone (Elsevier Limited); 2007.
Stracey J, Tracy R. Secondary pharmacaeutical production. In: Bennet W, Cole G, editors. Pharmaceutical production: an engineering guide. Rugby: Institution of Chemical Engineers; 2003.
Sinka IC, Motazedian F, Cocks ACF, Pitt KG. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol. 2009;189:276–84.
Kirsch D. Fixing tableting problems. Pharm Technol. 2015;39(5):58–9. http://www.pharmtech.com/fixing-tableting-problems. Accessed 25 May 2016.
Seaward D. Personal communication; 2016.
Porter SC. Coating of tablets and multiparticulates. In: Aulton ME, editor. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill-Livingstone (Elsevier Limited); 2007.
Cole ET, Cadé D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60(6):747–56.
Ku MS, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K. Performance qualification of a new hypromellose capsule: Part I. Comparative evaluation of physical, mechanical and processability quality attributes of VCaps Plus®, Quali-V® and gelatin capsules. Int J Pharm. 2010;386(1):30–41.
Tuleu C, Khela MK, Evans DF, Jones BE, Nagata S, Basit AW. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules. Eur J Pharm Sci. 2007;30(3):251–5.
Clarke. Personal communication; 2016.
Jones BE. Hard gelatin capsules. In: Aulton ME, editor. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill-Livingstone (Elsevier Limited); 2007.
Elder D. Personal communication; 2016.
MG2. Company Website. http://www.mg2.it/process/SitePages/Machines%20and%20speeds.aspx. Accessed 28 Apr 2016.
Honeywell. Honeywell Aclar Films (Product Brochure). https://www.honeywell-aclar.com/ProductInformation/Pages/WhatisAclar.aspx. Accessed 28 Apr 2016.
Staniforth J. Secondary processing training course. Amsterdam: Centre for Professional Advancement; 1995.
Jones BE. Personal communication; 2003.
Schaber SD, Gerogiorgis DI, Ramachandran R, Evans JMB, Barton PI, Trout BL. Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a case study. Ind Eng Chem Res. 2011;50:10083–92.
Basu P, Joglekar G, Rai S, Suresh P, Vernon J. Analysis of manufacturing costs in pharmaceutical companies. J Pharm Innov. 2008;3:30–40.
Suresh P, Basu PK. Improving pharmaceutical product development and manufacturing: impact on cost of drug development and cost of goods sold of pharmaceuticals. J Pharm Innov. 2008;3:175–87.
Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J. Examining the production costs of antiretroviral drugs. AIDS. 2006;20:1745–52.
Masoumi AH, Yu M, Nagurney A. A supply chain generalized network oligopoly model for pharmaceuticals under brand differentiation and perishability. Transp Res Part E. 2012;48:762–80.
Papageorgiou LG. Supply chain optimisation for the process industries: advances and opportunities. Comput Chem Eng. 2009;33:1931–8.
Rossetti CL, Handfield R, Dooley KJ. Forces, trends, and decisions in pharmaceutical supply chain management. Int J Phys Distrib Logist Manag. 2011;41(6):601–22.
Sousa RT, Liu S, Papageorgiou LG, Shah N. Global supply chain planning for pharmaceuticals. Chem Eng Res Des. 2011;89:2396–409.
Susarla N, Karimi IA. Integrated supply chain planning for multinational pharmaceutical enterprises. Comput Chem Eng. 2012;42:168–77.
Mascia S, Heider PL, Zhang H, Lakerveld R, Benyahia B, Barton PI, Braatz RD, Cooney CL, Evans JMB, Jamison TF, Jensen KF, Myerson AS, Trout BL. End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. Angew Chem Int. 2013;52:12359–63.
Plumb K. Continuous processing in the pharmaceutical industry: changing the mind set. Chem Eng Res Des. 2005;83(A6):730–8.
Lee SL, O’Connor TF, Yang X, Cruz CN, Chatterjee S, Madurawe RD, Moore CMV, Yu LX, Woodcock J. Modernizing pharmaceutical manufacturing: from batch to continuous production. J Pharm Innov. 2015; 10:191.
Poechlauer P, Manley J, Broxterman R, Gregersten B, Ridemark M. Continuous processing in the manufacture of active pharmaceutical ingredients and finished dosage forms: an industry perspective. Org Process Res. 2012;16:1586–90.
Singh R, Ierapetritou M, Ramachandran R. An engineering study on the enhanced control and operation of continuous manufacturing of pharmaceutical tablets via roller compaction. Int J Pharm. 2012; 438(1-2):307-26.
Singh R, Sahay A, Karry KM, Muzzio F, Ierapetritou M, Ramachandran R. Implementation of an advanced hybrid MPC–PID control system using PAT tools into a direct compaction continuous pharmaceutical tablet manufacturing pilot plant. Int J Pharm. 2014;473:38–54.
Salunke S, Hempenstall J, Kendall R, Roger B, Mroz C, Nunn T, Tuleu C. European Pediatric formulation initiative’s (EuPFI) 2nd conference commentary—formulating better medicines for children. Int J Pharm. 2011;419:235–9.
Sam T, Ernest TB, Walsh J, Williams JL on behalf of the European Pediatric Formulation Initiative (EuPFI). A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms—an application for Pediatric dosage form selection. Int J Pharm. 2012;435:115–23.
Standing JF, Tuleu C. Pediatric formulations—getting to the heart of the problem. Int J Pharm. 2005;300:56–66.
Orlu-Gul M, Raimi-Abraham B, Jamieson E, Wei L, Murray M, Stawarz K, Stegemann S, Tuleu C, Smith FJ. Public engagement workshop: how to improve medicines for older people? Int J Pharm. 2014;459:65–9.
Stegemann S, Baeyens J-P, Cerreta F, Chanie E, Lofgren A, Maio M, Schreier G, Thesing-Bleck E. Adherence measurement systems and technology for medications in older patient populations. Eur Geriatr Med. 2012;3:254–60.
Stegemann S, Gosch M, Breitkreutz J. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm. 2012;430:197–206.
Stegemann S, Baeyens J-P, Becker R, Maio M, Bresciani M, Shreeves T, Ecker F, Gogol M. Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models. Z Gerontol Geriat. 2014;47:285–7.
Perrie Y, Badhan RKS, Kirby DJ, Lowry D, Mohammed AR, Ouyang D. The impact of ageing on the barriers to drug delivery. J Control Release. 2012;161:389–98.
Stegemann S, Eckerb F, Maio M, Kraahs P, Wohlfart R, Breitkreutz J, Zimmer A, Bar-Shalom D, Hettrich P, Broegmann B. Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev. 2010;9:384–98.
Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, Flanagan T, Tuleu C. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in pediatric and geriatric populations. Drugs. 2014;74:1871–89.
Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)—a novel solid oral dosage form for pediatric use. Eur J Pharm Biopharm. 2011;78:462–9.
Ernest. Personal communication; 2016.
Sandri G, Bonferoni MC, Ferrari F, Rossi S, Caramella C. Differentiating factors between oral fast-dissolving technologies. Am J Drug Deliv. 2006;4(4):249–62.
Jonathan G, Karim A. 3-D printing in pharmaceutics: a new tool for designing customised delivery systems. Int J Pharm. 2016; 376–94.
Goyanes A, Buanz ABM, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476:88–92.
Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, Gaisford S, Basit AW. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm. 2015;496:414–20.
Goyanes A, Martinez PR, Buanz ABM, Basit AW, Gaisford S. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 2015;494(2015):657–63.
Goyanes A, Wang J, Buanz A, Martinez-Pacheco R, Telford R, Gaisford S, Basit AW. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharm. 2015;12:4077–84.
Khaled SA, Burley JC, Alexander MR, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm. 2014;461:105–11.
Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm. 2015;494:643–50.
Palmer E. Company builds plant for 3DP pill making as it nails first FDA approval. Fierce Biotech Newsletter. 3 Aug 2015. http://www.fiercepharmamanufacturing.com/story/fda-approves-seizure-drug-made-3-d-technology/2015-08-03. Accessed 28 Feb 2016.
Disch T, Haala J, Koeberle M. Hot-melt coated immediate-release taste-masked paracetamol and caffeine orally-disintegrating granules. Pullach: Hermes Pharma; 2016.
Klingmann V, Seitz A, Meissner T, Breitkreutz J, Moeltner A, Bosse HM. Acceptability of uncoated mini-tablets in neonates—a randomized controlled trial. J Pediatr. 2015;167(4):893–6.
Tissen C, Woertz K, Breitkreutz J, Kleinebudde P. Development of mini-tablets with 1 mm and 2 mm diameter. Int J Pharm. 2011;416:164–70.
Bredenberg S, Nyholm D, Aquilonius S-M, Nyström C. An automatic dose dispenser for microtablets—a new concept for individual dosage of drugs in tablet form. Int J Pharm. 2003;261:137–46.
Lam JKW, Xu Y, Worsley A, Wong ICK. Oral transmucosal drug delivery for pediatric use. Adv Drug Deliv Rev. 2014;73:50–62.
Madhav NVS, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review. J Control Release. 2009;140:2–11.
Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Delivery. 2011;8(3):299–316.
Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139:94–107.
Borges AF, Silva C, Coelho JFJ, Simões S. Oral films: current status and future perspectives. I—Galenical development and quality attributes. J Control Release. 2015;206(2015):1–19.
Hutchison KG, Ferdinando J. Soft gelatin capsules. In: Aulton ME, editor. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill-Livingstone (Elsevier Limited); 2007.
Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm. 2011;404:1–9.
Preis M, Breitkreutz J, Sandler N. Perspective: concepts of printing technologies for oral film formulations. Int J Pharm. 2015;494:578–84.
Capsugel (2011) Capsugel acquires Novel FlexTab™ drug delivery technology, enhancing value for customers (Press Release, 9 Feb 2011). http://www.capsugel.com/news-events/news/capsugel-acquires-novel-flextabtm-drug-delivery-technology-enhancing-value. Accessed 24 May 2016.
Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci. 2015;75:2–9.
Acknowledgements
The author gratefully thanks A Clarke, D Dinner, D Elder, T Ernest, D Seaward and S van den Ban for graciously and kindly providing comments on a draft version of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Wilson, M.W. (2016). Manufacturing Platforms for Patient-Centric Drug Products. In: Stegemann, S. (eds) Developing Drug Products in an Aging Society. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-43099-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-43099-7_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43097-3
Online ISBN: 978-3-319-43099-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)